Mark Moody, Ph.D. of Activate Presents at STING&TLR-Targeting Therapies conference

Mark Moody, Ph.D. of Activate presented “Nanomedicine Formulations for TLR Agonist Drug Combinations” at the March 22-24 STING&TLR-Targeting Therapies conference.